Infections drive most lupus hospitalizations, cardiovascular disease tops deaths
A retrospective study of 89 hospitalized lupus patients found infections caused 51.6 percent of admissions while cardiovascular disease accounted for ...
A retrospective study of 89 hospitalized lupus patients found infections caused 51.6 percent of admissions while cardiovascular disease accounted for ...
Liraglutide reduced proteinuria and kidney injury in lupus-prone mice through anti-inflammatory, antioxidant, and ferroptosis-related mechanisms, with cAMP signaling implicated.
A new comparative review finds that the type II anti-CD20 antibody obinutuzumab succeeded in Phase 3 lupus trials where rituximab ...
A cross-sectional study of 60 lupus patients found serum autotaxin levels rose with disease activity and distinguished active lupus nephritis ...
A prospective 12-month cohort study of 36 Saudi patients with lupus found that belimumab add-on therapy was associated with significant ...
A network meta-analysis of 15 randomized trials ranks telitacicept highest for SRI-4 response in lupus but links it to more ...
A survey of ten leading Bulgarian rheumatologists and nephrologists finds that lupus nephritis affects about 35 percent of systemic lupus ...
New research in mice shows that curli amyloid fibers from Salmonella and E. coli biofilms can drive the production of ...
New research shows that the antiviral protein IFIT1 is elevated in immune cells of lupus patients, where it promotes cell ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.